It is a pharma private limited company based in Ankleshwar, Gujarat, India, established in 2020.
2020 | Ankleshwar, Gujarat, India | ActiveSurmount Formulations Private Limited, a active private limited company, was established on 29 September 2020 in Ankleshwar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304GJ2020PTC116901. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Dhirendra Maganlal Mehta (Director), Kavit Dhirendrakumar Mehta (Director). It holds ₹5.00 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. F-16- 17- 18/B, Plot 73, Roshni Plaza Shopping Center, Station Road, Ankleshwar, Gujarat, 393002.
U24304GJ2020PTC116901
116901
29 September 2020
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Surmount Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhirendra Maganlal Mehta | Director | 29 Sep 2020 | Current |
| Kavit Dhirendrakumar Mehta | Director | 29 Sep 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Surmount Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 87.85% decrease. The company also saw a substantial fall in profitability, with a 53.9% decrease in profit. The company's net worth Soared by an impressive increase of 15.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Surmount Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2021 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Surmount Formulations has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Surmount Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surmount Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 25 Mar 2021 via Charge ID 100436883 with Others was fully satisfied on 24 Jun 2025. was documented.
The activity Surmount Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Surmount Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
A charge with Others amounted to Rs. 50.00 M with Charge ID 100436883 was registered on 25 Mar 2021. was recorded as a recent event.
The activity Dhirendra Maganlal Mehta was appointed as a Director was appointed as a Director on 29 Sep 2020 & has been associated with this company since 5 years 1 month . was completed.
The activity Kavit Dhirendrakumar Mehta was appointed as a Director was appointed as a Director on 29 Sep 2020 & has been associated with this company since 5 years 1 month . was completed.
The CIN of Surmount Formulations Private Limited is U24304GJ2020PTC116901.
Surmount Formulations Private Limited is headquartered at Shop No. F-16- 17- 18/B, Plot 73, Roshni Plaza Shopping Center, Station Road, Ankleshwar, Gujarat, 393002.
Surmount Formulations Private Limited was incorporated on 29 September 2020.
The current directors of Surmount Formulations Private Limited are
The primary industry of Surmount Formulations Private Limited is Manufacturing.
Surmount Formulations Private Limited is unlisted.
The authorized capital of Surmount Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX